JP2025515483A5 - - Google Patents
Info
- Publication number
- JP2025515483A5 JP2025515483A5 JP2024563508A JP2024563508A JP2025515483A5 JP 2025515483 A5 JP2025515483 A5 JP 2025515483A5 JP 2024563508 A JP2024563508 A JP 2024563508A JP 2024563508 A JP2024563508 A JP 2024563508A JP 2025515483 A5 JP2025515483 A5 JP 2025515483A5
- Authority
- JP
- Japan
- Prior art keywords
- alkenyl
- alkynyl
- heterocyclyl
- heteroaryl
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2022090343 | 2022-04-29 | ||
| CNPCT/CN2022/090343 | 2022-04-29 | ||
| PCT/CN2023/091482 WO2023208172A1 (en) | 2022-04-29 | 2023-04-28 | Substituted 7- (pyrimidin-4-yl) quinolin-4 (1h) -one compounds as cyclin dependent kinase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025515483A JP2025515483A (ja) | 2025-05-15 |
| JP2025515483A5 true JP2025515483A5 (enExample) | 2026-05-11 |
Family
ID=88517884
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024563508A Pending JP2025515483A (ja) | 2022-04-29 | 2023-04-28 | サイクリン依存性キナーゼ阻害剤としての置換７－（ピリミジン－４－イル）キノリン－４（１ｈ）－オン化合物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250136586A1 (enExample) |
| EP (1) | EP4514797A4 (enExample) |
| JP (1) | JP2025515483A (enExample) |
| KR (1) | KR20250004015A (enExample) |
| CN (1) | CN119053598A (enExample) |
| AU (1) | AU2023263197A1 (enExample) |
| CA (1) | CA3250944A1 (enExample) |
| CO (1) | CO2024014593A2 (enExample) |
| IL (1) | IL316564A (enExample) |
| MX (1) | MX2024013264A (enExample) |
| WO (1) | WO2023208172A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202513069A (zh) | 2023-07-21 | 2025-04-01 | 美商冰洲石生物科技公司 | 作為週期蛋白依賴性激酶抑制劑之胺基嘧啶衍生物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3816119A1 (de) * | 1988-05-11 | 1989-11-23 | Bayer Ag | 7-substituierte chinolon- und naphthyridoncarbonsaeure-derivate |
| US6080757A (en) * | 1996-06-06 | 2000-06-27 | Pfizer Inc | Antibiotic quinolones and derivatives |
| HRP20180483T1 (hr) * | 2011-08-31 | 2018-05-04 | Otsuka Pharmaceutical Co., Ltd. | Spoj kinolona |
| WO2019161224A1 (en) * | 2018-02-15 | 2019-08-22 | GiraFpharma LLC | Heterocyclic compounds as kinase inhibitors |
| CN118286225A (zh) * | 2018-04-26 | 2024-07-05 | 辉瑞公司 | 作为细胞周期蛋白依赖性激酶抑制剂的2-氨基-吡啶或2-氨基-嘧啶衍生物 |
| CA3150689A1 (en) * | 2019-08-14 | 2021-02-18 | Nuvation Bio Inc. | Heterocyclic compounds as kinase inhibitors |
| WO2022236256A1 (en) * | 2021-05-03 | 2022-11-10 | Nuvation Bio Inc. | Heterocyclic compounds as kinase inhibitors |
-
2023
- 2023-04-28 WO PCT/CN2023/091482 patent/WO2023208172A1/en not_active Ceased
- 2023-04-28 CN CN202380035007.4A patent/CN119053598A/zh active Pending
- 2023-04-28 KR KR1020247039642A patent/KR20250004015A/ko active Pending
- 2023-04-28 CA CA3250944A patent/CA3250944A1/en active Pending
- 2023-04-28 IL IL316564A patent/IL316564A/en unknown
- 2023-04-28 EP EP23795604.0A patent/EP4514797A4/en active Pending
- 2023-04-28 AU AU2023263197A patent/AU2023263197A1/en active Pending
- 2023-04-28 JP JP2024563508A patent/JP2025515483A/ja active Pending
-
2024
- 2024-10-25 US US18/926,544 patent/US20250136586A1/en active Pending
- 2024-10-25 CO CONC2024/0014593A patent/CO2024014593A2/es unknown
- 2024-10-25 MX MX2024013264A patent/MX2024013264A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022532706A5 (enExample) | ||
| CN115734966A (zh) | 杂环化合物及其用途 | |
| JP2025516213A5 (enExample) | ||
| JP2007531760A5 (enExample) | ||
| JP6824952B2 (ja) | ｍＩＤＨ１阻害剤としての２−アリール−および２−アリールアルキル−ベンズイミダゾール | |
| JP2023531709A5 (enExample) | ||
| JP2005320351A5 (enExample) | ||
| JP2022504620A5 (enExample) | ||
| JP2018534301A5 (enExample) | ||
| CA2683534A1 (en) | Novel pyrimidine compound having dibenzylamine structure and medicament comprising the same | |
| JP2016530210A (ja) | ヘテロ環式ビニルオートタキシン阻害剤化合物 | |
| WO2011116066A1 (en) | Derivatives of dimethylcurcumin | |
| TW202214626A (zh) | 雌激素受體調節劑化合物及其用途 | |
| PT2029583E (pt) | Novos derivados de benzotiazinona e respectivo uso como agentes antibacterianos | |
| WO2019204505A2 (en) | K-ras modulators with a vinyl sulfonamide moiety | |
| JP2021535125A (ja) | Ｔｒｋ阻害剤としてのイミダゾ［１，２−ｂ］ピリダジン | |
| US10105373B2 (en) | Fused triterpene compounds and uses thereof | |
| CA3231311A1 (en) | Substituted 1,4-dihydro-1,6-naphthyridine amide and use thereof | |
| US9458170B2 (en) | Compound of camptothecin and preparation and use thereof | |
| WO2021254389A1 (zh) | 作为Wee-1抑制剂的吡唑并[3，4-d]嘧啶-3-酮衍生物 | |
| TW202404977A (zh) | 一種嘧啶并五員雜環化合物、其製備方法和用途 | |
| JP5319457B2 (ja) | 新規なジベンジルアミン構造を有するピリミジン化合物及びこれを含有する医薬 | |
| JP2008521775A (ja) | 炎症性疾患治療用の置換プテリジン | |
| US20140128469A1 (en) | Deuterated n-butyl bumetanide | |
| WO2022171128A1 (zh) | 作为Wee-1抑制剂的吡唑并[3,4-d]嘧啶-3-酮衍生物 |